SKIBSTED RUSSELL Insider Trades

Insider Trading History

Track insider trading activity for SKIBSTED RUSSELL. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $23.7k 8,466 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.89k 1,984 shares
$2.97
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $18.2k 6,498 shares
Last Trade
Apr 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.89k 2,190 shares
$2.69
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $12.1k 4,308 shares
Last Trade
Apr 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.89k 1,984 shares
$2.97
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $6.51k 2,324 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.9k 2,324 shares
$2.54
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $907k 324,000 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.8k 324,000 shares
$0.20
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $5.05M 1,803,044 shares
Last Trade
Jul 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 1,775,044 shares
$0.25
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $78.4k 28,000 shares
Last Trade
Jul 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49k 28,000 shares
$1.75
$2.80
Alimera Sciences
Alimera Sciences ALIM
Chief Financial Officer & SVP
Holding Value $277k 50,000 shares
Last Trade
Nov 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 50,000 shares
$3.38
$5.54
Alimera Sciences
Alimera Sciences ALIM
Chief Financial Officer & SVP
Holding Value $418k 75,500 shares
Last Trade
Mar 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.4k 58,000 shares
$1.35
$5.54
Alimera Sciences
Alimera Sciences ALIM
Chief Financial Officer & SVP
Holding Value $97k 17,500 shares
Last Trade
Jan 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.4k 17,500 shares
$2.82
$5.54
Alimera Sciences
Alimera Sciences ALIM
Chief Financial Officer & SVP
Holding Value $291k 52,500 shares
Last Trade
Jan 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 52,500 shares
$2.82
$5.54
Rockwell Medical
Rockwell Medical RMTI
See Remarks
Holding Value $54.1k 80,000 shares
Last Trade
Sep 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 80,000 shares
$1.66
$0.68
Rockwell Medical
Rockwell Medical RMTI
See Remarks
Holding Value $101k 150,000 shares
Last Trade
Sep 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.01M 150,000 shares
$13.42
$0.68
Rockwell Medical
Rockwell Medical RMTI
See Remarks
Holding Value $405k 600,000 shares
Last Trade
Sep 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.05M 600,000 shares
$13.42
$0.68
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $13.5k 11,250 shares
Last Trade
Dec 18, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2k 22,500 shares
$1.03
$1.20
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $28.9k 24,078 shares
Last Trade
Dec 18, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.01k 7,781 shares
$1.03
$1.20
Eterna Therapeutics
Eterna Therapeutics ERNA
Chief Financial Officer
Holding Value $255k 31,859 shares
Last Trade
Dec 18, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.8M 22,500 shares
$1,278.00
$8.01
Eterna Therapeutics
Eterna Therapeutics ERNA
Chief Financial Officer
Holding Value $193k 24,078 shares
Last Trade
Dec 18, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.94M 7,781 shares
$1,278.00
$8.01
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Chief Financial Officer
Holding Value $38.2k 31,859 shares
Last Trade
Dec 18, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2k 22,500 shares
$1.03
$1.20
Eterna Therapeutics
Eterna Therapeutics ERNA
Chief Financial Officer
Holding Value $90.1k 11,250 shares
Last Trade
Dec 18, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.8M 22,500 shares
$1,278.00
$8.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up